Rebeca Melara

Investigation of the Pharmacokinetics of Romiplostim in Rodents with a Focus on the Clearance Mechanism

Yow‐Ming Wang, Bethlyn Sloey, Teresa Wong et al. · Pharmaceutical Research · 2011 · 39 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Exposure–response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection

Jianfeng Lü, Erik Rasmussen, Beth Y. Karlan et al. · Cancer Chemotherapy and Pharmacology · 2011 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients

Jianfeng Lü, Laurent Claret, Liviawati Sutjandra et al. · Cancer Chemotherapy and Pharmacology · 2010 · 28 citations

Medicine, Oncology, Pharmacology +16

A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

Ignace Vergote, Russell J. Schilder, Charles H. Pippitt et al. · Gynecologic Oncology · 2014 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer

Richard H. De Boer, Dusan Kotasek, Shane White et al. · Breast Cancer Research and Treatment · 2012 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17